In a new study, scientists have identified a small molecule candidate drug that triggers the formation of left-handed Z-DNA in cells that in turn activates a highly immunogenic programmed pathway of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback